U.S. Markets close in 1 hr 39 mins
  • S&P 500

    3,467.87
    +40.95 (+1.19%)
     
  • Dow 30

    28,494.51
    +299.09 (+1.06%)
     
  • Nasdaq

    11,605.57
    +126.69 (+1.10%)
     
  • Russell 2000

    1,628.54
    +14.92 (+0.92%)
     
  • Crude Oil

    41.48
    +0.65 (+1.59%)
     
  • Gold

    1,917.40
    +5.70 (+0.30%)
     
  • Silver

    25.05
    +0.35 (+1.43%)
     
  • EUR/USD

    1.1836
    +0.0063 (+0.5326%)
     
  • 10-Yr Bond

    0.7890
    +0.0280 (+3.68%)
     
  • Vix

    28.64
    -0.54 (-1.85%)
     
  • GBP/USD

    1.2944
    +0.0003 (+0.0233%)
     
  • USD/JPY

    105.4370
    +0.0070 (+0.0066%)
     
  • BTC-USD

    11,940.38
    +883.38 (+7.99%)
     
  • CMC Crypto 200

    239.83
    +0.91 (+0.38%)
     
  • FTSE 100

    5,889.22
    +4.57 (+0.08%)
     
  • Nikkei 225

    23,567.04
    -104.09 (-0.44%)
     

One Thing To Remember About The MYOS RENS Technology Inc. (NASDAQ:MYOS) Share Price

Simply Wall St

Anyone researching MYOS RENS Technology Inc. (NASDAQ:MYOS) might want to consider the historical volatility of the share price. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. The first category is company specific volatility. This can be dealt with by limiting your exposure to any particular stock. The other type, which cannot be diversified away, is the volatility of the entire market. Every stock in the market is exposed to this volatility, which is linked to the fact that stocks prices are correlated in an efficient market.

Some stocks are more sensitive to general market forces than others. Beta is a widely used metric to measure a stock's exposure to market risk (volatility). Before we go on, it's worth noting that Warren Buffett pointed out in his 2014 letter to shareholders that 'volatility is far from synonymous with risk.' Having said that, beta can still be rather useful. The first thing to understand about beta is that the beta of the overall market is one. A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market. In comparison a stock with a beta of over one tends to be move in a similar direction to the market in the long term, but with greater changes in price.

View our latest analysis for MYOS RENS Technology

What we can learn from MYOS's beta value

Looking at the last five years, MYOS RENS Technology has a beta of 0.81. The fact that this is well below 1 indicates that its share price movements haven't historically been very sensitive to overall market volatility. If history is a good guide, owning the stock should help ensure that your portfolio is not overly sensitive to market volatility. Beta is worth considering, but it's also important to consider whether MYOS RENS Technology is growing earnings and revenue. You can take a look for yourself, below.

NasdaqCM:MYOS Income Statement, August 12th 2019
NasdaqCM:MYOS Income Statement, August 12th 2019

Could MYOS's size cause it to be more volatile?

MYOS RENS Technology is a noticeably small company, with a market capitalisation of US$15m. Most companies this size are not always actively traded. Very small companies often have a low beta value because their share prices are not well correlated with market volatility. This could be because the price is reacting to company specific events. Alternatively, the shares may not be actively traded.

What this means for you:

The MYOS RENS Technology doesn't usually show much sensitivity to the broader market. This could be for a variety of reasons. Typically, smaller companies have a low beta if their share price tends to move a lot due to company specific developments. Alternatively, an strong dividend payer might move less than the market because investors are valuing it for its income stream. In order to fully understand whether MYOS is a good investment for you, we also need to consider important company-specific fundamentals such as MYOS RENS Technology’s financial health and performance track record. I urge you to continue your research by taking a look at the following:

  1. Financial Health: Are MYOS’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.

  2. Past Track Record: Has MYOS been consistently performing well irrespective of the ups and downs in the market? Go into more detail in the past performance analysis and take a look at the free visual representations of MYOS's historicals for more clarity.

  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.